Daniel Rosenberg
Daniel Rosenberg is an analyst at Paradigm Capital, specializing in the technology and video infrastructure sectors. He recently expressed a positive view on Haivision Systems Inc., noting improvements in profitability and operational efficiency despite facing revenue challenges due to macro uncertainty.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 8.00 | 0.03% | +0% | 331,002,651 | 104,847 | $21,000,000 | 6,652$ |
| Totals | 1 | 331,002,651 | 104,847 | $21,000,000 | 6,652$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Daniel Rosenberg is the director of the colon cancer prevention program at the Carole and Ray Neag Comprehensive Cancer Center in Connecticut.
8
Romania:
Daniel Rosenberg is a researcher at the University of Connecticut and co-author of the study on the health benefits of walnuts.
9
Canada:
Daniel Rosenberg bumped his Sabio Holdings Inc. target to $1.50 with a 'buy' rating.
7
Canada:
Daniel Rosenberg thinks Haivision Systems Inc. is 'operating more efficiently and is more profitable compared to last year.'
7